Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CMPD OTCMKTS:CRMZ NYSEARCA:FFR NASDAQ:MCTR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCMPDCompuMed$4.50+12.5%$4.01$2.40▼$6.80$5.97M-0.05916 shs100 shsCRMZCreditRiskMonitor.com$2.33+7.8%$2.34$2.01▼$3.60$23.26M0.035,701 shs515 shsFFRFirst Trust Alerian Disruptive Technology Real Estate ETF$0.00$36.16▼$55.68$23.60MN/A2,034 shs2,400 shsMCTRCTRL Group$2.20-6.0%$2.13$1.33▼$54.91$35.80MN/A252,080 shs525,974 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCMPDCompuMed0.00%-3.43%0.00%+38.04%+28.57%CRMZCreditRiskMonitor.com+7.78%+6.79%-1.36%-4.69%+3.47%FFRFirst Trust Alerian Disruptive Technology Real Estate ETF0.00%0.00%0.00%0.00%0.00%MCTRCTRL Group-5.98%+25.00%+22.91%-46.47%+219,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCMPDCompuMed$4.50+12.5%$4.01$2.40▼$6.80$5.97M-0.05916 shs100 shsCRMZCreditRiskMonitor.com$2.33+7.8%$2.34$2.01▼$3.60$23.26M0.035,701 shs515 shsFFRFirst Trust Alerian Disruptive Technology Real Estate ETF$0.00$36.16▼$55.68$23.60MN/A2,034 shs2,400 shsMCTRCTRL Group$2.20-6.0%$2.13$1.33▼$54.91$35.80MN/A252,080 shs525,974 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCMPDCompuMed0.00%-3.43%0.00%+38.04%+28.57%CRMZCreditRiskMonitor.com+7.78%+6.79%-1.36%-4.69%+3.47%FFRFirst Trust Alerian Disruptive Technology Real Estate ETF0.00%0.00%0.00%0.00%0.00%MCTRCTRL Group-5.98%+25.00%+22.91%-46.47%+219,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCMPDCompuMed 0.00N/AN/AN/ACRMZCreditRiskMonitor.com 0.00N/AN/AN/AFFRFirst Trust Alerian Disruptive Technology Real Estate ETF 0.00N/AN/AN/AMCTRCTRL Group 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCMPDCompuMed$6.22M0.96$0.69 per share6.54$2.49 per share1.81CRMZCreditRiskMonitor.com$19.81M1.27$0.19 per share12.38$1.04 per share2.24FFRFirst Trust Alerian Disruptive Technology Real Estate ETFN/AN/AN/AN/AN/AN/AMCTRCTRL GroupN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCMPDCompuMed$30K$0.1726.47∞N/A2.26%4.82%3.32%N/ACRMZCreditRiskMonitor.com$1.67M$0.1614.55∞N/A9.04%16.29%7.15%11/12/2025 (Estimated)FFRFirst Trust Alerian Disruptive Technology Real Estate ETFN/AN/A0.00N/AN/AN/AN/AN/AN/AMCTRCTRL GroupN/AN/A0.00∞N/AN/AN/AN/AN/ALatest CMPD, MCTR, FFR, and CRMZ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025CRMZCreditRiskMonitor.comN/A$0.02N/A$0.02N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCMPDCompuMedN/AN/AN/AN/AN/ACRMZCreditRiskMonitor.comN/AN/AN/AN/AN/AFFRFirst Trust Alerian Disruptive Technology Real Estate ETF$1.995.38%N/AN/AN/AMCTRCTRL GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCMPDCompuMed0.162.282.26CRMZCreditRiskMonitor.comN/A1.111.11FFRFirst Trust Alerian Disruptive Technology Real Estate ETFN/AN/AN/AMCTRCTRL GroupN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCMPDCompuMedN/ACRMZCreditRiskMonitor.comN/AFFRFirst Trust Alerian Disruptive Technology Real Estate ETFN/AMCTRCTRL GroupN/AInsider OwnershipCompanyInsider OwnershipCMPDCompuMed22.00%CRMZCreditRiskMonitor.com56.20%FFRFirst Trust Alerian Disruptive Technology Real Estate ETFN/AMCTRCTRL GroupN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCMPDCompuMed81.33 million1.03 millionNot OptionableCRMZCreditRiskMonitor.com9010.77 million4.72 millionNot OptionableFFRFirst Trust Alerian Disruptive Technology Real Estate ETF1,780640,000N/ANot OptionableMCTRCTRL Group2015.30 millionN/AN/ACMPD, MCTR, FFR, and CRMZ HeadlinesRecent News About These CompaniesCTRL Group Limited Announces Leadership Changes Effective August 2025July 31, 2025 | tipranks.comCTRL Group Limited Announces Name ChangeJuly 21, 2025 | globenewswire.comCTRL Group Limited Announces Executive Compensation AdjustmentsJuly 18, 2025 | tipranks.comCTRL Group Ltd trading resumesJune 5, 2025 | msn.comCTRL Group Ltd trading halted, volatility trading pauseJune 5, 2025 | msn.comCTRL Group Ltd.May 29, 2025 | wsj.comMCTR Ctrl Group LimitedMay 16, 2025 | seekingalpha.comCtrl Group Limited: Overvalued IPO Despite Strong Mobile Game Marketing ProspectsApril 29, 2025 | seekingalpha.comWhy Ctrl Group Limited’s (MCTR) Stock Is Down 11.53%April 5, 2025 | aaii.comAIPO Momentum Builds In 2025: Diginex, CTRL Group, And Others Post Strong GainsMarch 10, 2025 | benzinga.comCtrl Group Limited (MCTR)March 7, 2025 | finance.yahoo.comCTRL Group Ltd MCTRMarch 4, 2025 | morningstar.comMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCMPD, MCTR, FFR, and CRMZ Company DescriptionsCompuMed OTCMKTS:CMPD$4.50 +0.50 (+12.50%) As of 09/10/2025 09:30 AM EasternCompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.CreditRiskMonitor.com OTCMKTS:CRMZ$2.33 +0.17 (+7.78%) As of 09/10/2025 11:46 AM EasternCreditRiskMonitor.com, Inc. engages in the provision of interactive business-to-business software-as-a-service (Saas) subscription products for corporate credit and procurement professionals in the United States. The company's products include CreditRiskMonitor product provides subscribers with unlimited usage and coverage of public and private companies, featuring multi-period spreads of financial reports and ratio analysis, credit risk scores, payment-behavior scores, trend reports, peer analysis, and credit limit recommendations, as well as up-to-date financial news screened specifically for materiality in credit evaluation; and SupplyChainMonitor, creates a risk management solution built specifically for procurement, supply chain, sourcing, and finance personnel involved in the supplier lifecycle, risk assessment, and ongoing risk monitoring. It also offers add-on subscription services, including Credit Limit Service product, available on the CreditRiskMonitor platform product, helps subscribers manage credit line limits for their customers, in light of changes in the customers' financial strength; Financial Statement Processing, and Confidential Financial Statement Tool products, provides subscribers a flexible option to help ease their process in the data entry and standardization of private company financial statements, as well as provides private company FRISK scores; and Confidential Financial Statement Portal, allows subscribers to invite their private company counterparties to enter or upload confidential financial statements to standardize and score to provide private company FRISK scores. The company was incorporated in 1977 and is based in Valley Cottage, New York. CreditRiskMonitor.com, Inc. operates as a subsidiary of Flum Partners.First Trust Alerian Disruptive Technology Real Estate ETF NYSEARCA:FFRFirst Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund (the Fund), formerly First Trust FTSE EPRA/NAREIT Global Real Estate Index Fund, is an exchange-traded fund. The Fund seeks investment results that correspond to the price and yield of an equity index called the FTSE EPRA/NAREIT Developed Index (the Index). The Index is designed to measure the stock performance of companies engaged in specific real estate activities of the North American, European and Asian real estate markets. Relevant real estate activities are defined as the ownership, trading and development of income-producing real estate. The constituents of the Index are required to meet individual geographic criteria, and are subject to size, liquidity and free-float screens. The Index is a modified market capitalization-weighted index, based on free-float market capitalization. The Index is rebalanced and reconstituted quarterly. The Fund's investment advisor is First Trust Advisors L.P.CTRL Group NASDAQ:MCTR$2.20 -0.14 (-5.98%) As of 09/10/2025 04:00 PM EasternCtrl Group Ltd. is a holding company, which engages in the provision of marketing and advertising services. It offers one-stop advertising services to clients throughout the entire advertising process, which comprises the planning, creating, launching, managing, and performance monitoring of the advertisements. The company was founded by Kai Kwan Lam, Chi Fung Lau, and Chun Pong Siu on May 13, 2022 and is headquartered in Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Despite Pullback, Rocket Lab Still Looks Primed for a Breakout Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook Celsius Stock Surges After Blowout Earnings and Pepsi Deal Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Alphabet Stock’s Weakness Was Wall Street’s Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
